What is a positive sentinel lymph node in a breast cancer patient? A practical approach

被引:20
作者
Cserni, Gabor [1 ]
机构
[1] Bacs Kiskun Cty Teaching Hosp, Dept Pathol, H-6000 Kecskemet, Hungary
关键词
sentinel lymph node; breast cancer; metastasis; isolated tumour cells; TNM;
D O I
10.1016/j.breast.2006.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sentinel lymph node (SN) biopsy has become increasingly used for the staging of breast carcinoma, resulting in the upstaging of this disease, and this has led to concerns with regard to what should be considered a positive SN. Factors influencing the positive staging of an SN include metastasis size, the method used for metastasis detection, the definition of metastasis and the individual pathologist. Until evidence to the contrary emerges, an SN should be considered positive if metastases (nodal involvement > 0.2 mm in the largest dimension) are detected in it by histology. A target size should be identified, and SNs, as the most likely sites of nodal metastases, should be searched systematically to find (nearly) all of the targeted metastases. The European guidelines for SN assessment have set two such target sizes: as a minimum, at( metastases > 2mm should be identified, and optimally all micrometastases should also be sought. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:152 / 160
页数:9
相关论文
共 66 条
  • [1] Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma
    Bleiweiss, IJ
    Nagi, CS
    Jaffer, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) : 2013 - 2018
  • [2] Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection
    Calhoun, KE
    Hansen, NM
    Turner, RR
    Giuliano, AE
    [J]. AMERICAN JOURNAL OF SURGERY, 2005, 190 (04) : 588 - 591
  • [3] Benign transport of breast epithelium into axillary lymph nodes after biopsy
    Carter, BA
    Jensen, RA
    Simpson, JF
    Page, DL
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (02) : 259 - 265
  • [4] Size of breast cancer metastases in axillary lymph nodes: Clinical relevance of minimal lymph node involvement
    Colleoni, M
    Rotmensz, N
    Peruzzotti, G
    Maisonneuve, P
    Mazzarol, G
    Pruneri, G
    Luini, A
    Intra, M
    Veronesi, P
    Galimberti, V
    Torrisi, R
    Cardillo, A
    Goldhirsch, A
    Viale, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) : 1379 - 1389
  • [5] Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting
    Cserni, G.
    Sapino, A.
    Decker, T.
    [J]. BREAST, 2006, 15 (03) : 347 - 354
  • [6] The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma
    Cserni, G
    Bianchi, S
    Vezzosi, V
    Peterse, H
    Sapino, A
    Arisio, R
    Reiner-Concin, A
    Regitnig, P
    Bellocq, JP
    Marin, C
    Bori, R
    Penuela, JM
    Iturriagagoitia, A
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (05) : 518 - 522
  • [7] Cserni G, 2006, ANN SURG, V243, P287, DOI 10.1097/01.sla.0000198344.85427.9d
  • [8] Improving the reproducibility of diagnosing micrometastases and isolated tumor cells
    Cserni, G
    Bianchi, S
    Boecker, W
    Decker, T
    Lacerda, M
    Rank, F
    Wells, CA
    [J]. CANCER, 2005, 103 (02) : 358 - 367
  • [9] Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer
    Cserni, G
    Gregori, D
    Merletti, F
    Sapino, A
    Mano, MP
    Ponti, A
    Sandrucci, S
    Baltás, B
    Bussolati, G
    [J]. BRITISH JOURNAL OF SURGERY, 2004, 91 (10) : 1245 - 1252
  • [10] Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines
    Cserni, G
    Amendoeira, I
    Apostolikas, N
    Bellocq, JP
    Bianchi, S
    Bussolati, G
    Boecker, W
    Borisch, B
    Connolly, CE
    Decker, T
    Dervan, P
    Drijkoningen, M
    Ellis, IO
    Elston, CW
    Eusebi, V
    Faverly, D
    Heikkila, P
    Holland, R
    Kerner, H
    Kulka, J
    Jacquemier, J
    Lacerda, M
    Martinez-Penuela, J
    De Miguel, C
    Peterse, JL
    Rank, F
    Regitnig, P
    Reiner, A
    Sapino, A
    Sigal-Zafrani, B
    Tanous, AM
    Thorstenson, S
    Zozaya, E
    Wells, CA
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) : 1654 - 1667